Dr. D. CBD

Endocannabinoids in endocrine and related tumours.
Sep
21
2018

Endocannabinoids in endocrine and related tumours.

TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer.
Sep
21
2018

TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer.

Cannabidiol, a novel inverse agonist for GPR12.
Sep
21
2018

Cannabidiol, a novel inverse agonist for GPR12.

Written by Dr D / Cancer, CBD, GPR12
Antitumorigenic targets of cannabinoids – current status and implications.
Sep
21
2018

Antitumorigenic targets of cannabinoids – current status and implications.

Written by Dr D / Cancer
The influence of biomechanical properties and cannabinoids on tumor invasion.
Sep
21
2018

The influence of biomechanical properties and cannabinoids on tumor invasion.

Written by Dr D / Cancer
Cannabidiol as potential anticancer drug
Sep
21
2018

Cannabidiol as potential anticancer drug

Written by Dr D / Cancer, CBD
The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors
Sep
21
2018

The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors

Written by Dr D / Cancer
The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors
Sep
21
2018

The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors

Written by Dr D / Cancer
Towards the use of non-psychoactive cannabinoids for prostate cancer.
Sep
20
2018

Towards the use of non-psychoactive cannabinoids for prostate cancer.

Written by Dr D / Cancer, CBD, Prostate Cancer
In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines
Sep
20
2018

In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines

Written by Dr D / Cancer, Prostate Cancer